期 |
栏目 |
标题 |
文件 |
卷 78, 编号 6 (2003) |
Editorial |
Telmisartan (micardis) - an antagonist of angiotensin II receptors of type 1: one more antihypertensivedrug or something greater? |
|
卷 79, 编号 6 (2004) |
Editorial |
Cerebrovascular complications in metabolic syndrome: possible approaches to a lower risk |
|
卷 79, 编号 6 (2004) |
Editorial |
Cardiac arrest in a patient with obstructive sleep apnea |
|
卷 79, 编号 8 (2004) |
Editorial |
Thiaside diuretics in combination with inhibitors of angiotensin-converting enzyme in patients with diabetes mellitus type 2 comorbid with arterial hypertension |
|
卷 80, 编号 6 (2008) |
Editorial |
Resistent arterial hypertension |
|
卷 81, 编号 4 (2009) |
Editorial |
Quantitative repolarization indices in diagnosis of left ventricular hypertrophy in hypertensive patients |
|
卷 81, 编号 5 (2009) |
Editorial |
Combined treatment of arterial hypertension (results of the international program CLIP-ACCORD) |
|
卷 81, 编号 6 (2009) |
Editorial |
Affection of target organs in hypertensive patients with and without metabolic syndrome |
|
卷 84, 编号 9 (2012) |
Editorial |
Possibilities of using levosimendan in patients with idiopathic pulmonary hypertension |
|
卷 84, 编号 12 (2012) |
Editorial |
Use of nebivolol in patients with idiopathic pulmonary hypertension: Results of the pilot study |
|
卷 85, 编号 1 (2013) |
Editorial |
Results of implementation of a hypertension control program in Russia in 2002-2012 |
|
卷 85, 编号 1 (2013) |
Editorial |
Effect of bosentan on the clinical status and cellular immunity of patients with idiopathic pulmonary hypertension |
|
卷 85, 编号 10 (2013) |
Editorial |
Possibilities of rational combination antihypertensive therapy: Results of HEMERA international clinical trial |
|
卷 85, 编号 9 (2013) |
Editorial |
On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (Exforge - Clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure) |
|
卷 86, 编号 9 (2014) |
Editorial |
Clinical guidelines for the diagnosis and treatment of pulmonary hypertension |
|
卷 86, 编号 9 (2014) |
Editorial |
24-hour systolic wave increment index monitoring in patients with low-renin arterial hypertension |
|
卷 86, 编号 9 (2014) |
Editorial |
Pulmonary hypertension in Russia: The first results of the national register |
|
卷 86, 编号 12 (2014) |
Editorial |
Direct human DNA damage by unfavorable environmental and climatic factors |
|
卷 87, 编号 9 (2015) |
Editorial |
Comorbidity of cardiovascular diseases and cancers: Problems in the diagnosis of cardiotoxic effects of chemo- and radiation therapy |
|
卷 88, 编号 9 (2016) |
Editorial |
Clinical guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (Part 1) |
(Rus)
|
卷 88, 编号 8 (2016) |
Editorial |
A clinical case of hemangioma of the face and tongue concurrent with severe obstructive sleep apnea syndrome complicated by cardiac arrhythmias and conduction disturbances |
(Rus)
|
卷 88, 编号 12 (2016) |
Editorial |
A clinical case of long-term macitentan therapy in a female patient with idiopathic pulmonary hypertension |
(Rus)
|
卷 89, 编号 4 (2017) |
Editorial |
Subtraction CT angiopulmonographic assessment of the vascular bed and lung perfusion in patients with chronic thromboembolic pulmonary hypertension: A pilot study |
(Rus)
|
卷 89, 编号 9 (2017) |
Editorial |
Chronic thromboembolic pulmonary hypertension developed in a female patient with lupus erythematosus and secondary antiphospholipid syndrome |
(Rus)
|
卷 89, 编号 8 (2017) |
Editorial |
Bosentan use in pulmonary arterial hypertension: Russian and foreign experience |
(Rus)
|
卷 88, 编号 10 (2016) |
Editorial |
Clinical guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (Part 2) |
(Rus)
|
卷 78, 编号 8 (2003) |
Editorial |
Co-renitek treatment of patients withmoderate and severe forms of hypertensive disease |
|
卷 91, 编号 12 (2019) |
Editorial |
Evolution of pathogenetic therapy of pulmonary arterial hypertension |
(Rus)
|